Biocardia to host q3 2023 corporate update and financial results conference call on november 8, 2023

Sunnyvale, calif., nov. 01, 2023 (globe newswire) -- biocardia®, inc. [nasdaq:bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the three and nine months ended september 30, 2023 by conference call on wednesday, november 8, 2023 at 4:30 pm et. following management's formal remarks, there will be a question-and-answer session.
BCDA Ratings Summary
BCDA Quant Ranking